Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Cipla To Recalibrate US Investments
A More Measured Approach To US Generic R&D And Specialty
Feb 10 2020
•
By
Anju Ghangurde
Cipla Moderating Investments Across US Gx R&D, Specialty • Source: Shutterstock
More from Strategy
More from Business